NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide
Details
| Contract Title: | NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide |
| Published Date: | Feb 6, 2026 |
| Notice Type: | Notice (ContractNotice) |
| Value Banding: | High Value |
| Delivery Point: | United Kingdom |
Description:
NHS National Framework for Lenalidomide, Pomalidomide & Thalidomide. Offer reference number: CM/PHG/24/5716 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months. Periods of call-offs under the framework agreement: CM/PHG/24/5716/01– NHS National Framework for Lenalidomide, Pomalidomide & Thalidomide. CESW: (Midlands and Southwest): 1st June 2026 – 31st May 2028 NWLN: (North...